How I investigate acquired megaloblastic anemia

Area of Science:

• Hematology
• Clinical Pathology
• Nutritional Medicine

Background:

• Megaloblastic anemia (MA) encompasses a spectrum of clinical presentations, ranging from benign to severe.
• Vitamin B12 and folate deficiencies are primary causes, impacting DNA synthesis and red blood cell production.
• MA can present with pancytopenia or normal Mean Corpuscular Volume (MCV), complicating diagnosis.

Purpose of the Study:

• To review the classic and unique hematologic features of megaloblastic anemia in blood and bone marrow.
• To highlight diagnostic challenges, including mimicry of other hematologic conditions and the impact of partial treatment.
• To emphasize the critical need for prompt diagnosis and treatment to prevent irreversible sequelae, particularly neurological damage from vitamin B12 deficiency.

Main Methods:

• Review of existing literature on megaloblastic anemia.
• Analysis of characteristic findings in peripheral blood smears and bone marrow aspirates.
• Discussion of laboratory testing strategies and their limitations.

Main Results:

• MA exhibits diverse clinical and hematologic features, often mimicking thrombocytopenic purpura, myelodysplasia, and myeloid neoplasms.
• Pancytopenia and normal MCV are common presentations, posing diagnostic challenges.
• Partially treated MA presents a significant diagnostic pitfall.

Conclusions:

• High index of suspicion is essential for diagnosing MA, even with advanced laboratory testing.
• Prompt recognition and initiation of therapy are critical for preventing irreversible complications, especially neurological deficits in vitamin B12 deficiency.
• Hematopathologists face unique challenges in the rapid and accurate diagnosis of MA due to its varied presentation.